The EPA proposed this month more stringent restrictions on emissions from the 149 petroleum refineries in the US. The new rule would require monitoring of air at refinery fencelines to ensure compliance with standards. Coking units, tanks and flares would be subject to increased emission-control requirements, and the operational requirements of flares would be adjusted […]
Washington, DC 5/22/14—Roka Biosciences has filed to raise $75.0 million through a US IPO. Roka plans to list its shares on the NASDAQ stock exchange. Pricing details were not announced. Roka offers the Atlas instrument and Atlas Detection Assays for molecular-based automated foodborne-pathogen testing. Roka supplies tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin–producing […]
San Diego, CA 5/30/14; San Diego, CA 5/30/14—Sequenom has sold its Bioscience unit to Agena Bioscience, a Telegraph Hill Partners company, for $31.8 million and contingent consideration of up to $4 million. The Bioscience business manufactures and sells the MALDI-TOF MS–based MassARRAY platform for genetic analysis in research and clinical labs. Agena will retain all […]
Hilden, Germany and Germantown, MD 5/20/14—QIAGEN has acquired BIOBASE, a provider of expertly curated biological databases, for an undisclosed amount. BIOBASE products include the HGMD Human Gene Mutation Database on human inherited-disease mutations and the PGMD PharmacoGenomic Mutation Database, which identifies all published gene variants that affect patient drug response. “With HGMD and other content […]
New York, NY 5/22/14—The Wall Street Journal reported that VWR is in talks about a possible IPO or sale, according to sources. VWR and owner Madison Dearborn Partners have talked with banks in recent weeks about an IPO to raise $750 million. Such an offering would value the equity in VWR at $4 billion. As […]
New York, NY 5/29/14—Citing anonymous sources, Bloomberg has reported that Thermo Fisher Scientific intends to sell its Cole-Parmer Instrument business, which supplies lab equipment. Cole-Parmer has annual EBITDA of $50 million. The sources stated the sale price could range from $500 million to $700 million. Thermo acquired Cole-Parmer as part of its 2006 purchase of […]
The calendar year first quarter provided few clear trends as large publicly held US analytical and life science instrument firms experienced mixed results, with strengths and weaknesses in market and geographic segments varying by company. The six laboratory instrument and product businesses whose quarterly revenues are detailed on pages 9–11 reported positive sales results for […]
Thermo Fisher Scientific and Life Technologies made their financial-reporting debut as one company (see IBO 4/15/13) with the release of Thermo’s first quarter earnings in April. The industry-changing acquisition united two of the top five analytical and life science instrument firms (see IBO 4/15/14), creating a company whose financial size and breadth of products dwarf […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
